2019-20 Chief residents announced; 2 follow GIM careers
Last week the Department of Medicine delivered news of the Chief Resident selections for 2019-2020 and we are thrilled to see that two have chosen to follow careers in general internal medicine!
5 from Medicine accepted to ALICE leadership program
School of Medicine Office for Faculty Development has announced the next class in its ALICE program, a leadership development opportunity for mid-career women faculty in the School of Medicine. Five participants in the next class are from the Department of Medicine.
Get ready for SGIM 2018!
Health IT: Empowering General Internists to Lead Digital Innovation, that's what this years's annual meeting of the Society of General Internal Medicine is about.
Lantos shares CMV research
We are proud to show off the work Dr. Paul Lantos, a member of general internal medicine and a researcher in pediatric infectious diseases
Velazquez accepts new leadership role at Yale School of Medicine
Eric Velazquez, MD, has been appointed as chief of the Section of Cardiovascular Medicine in the Department of Internal Medicine, Chief of Cardiovascular Medicine at Yale-New Haven Hospital, and Physician-in-Chief of the Heart and Vascular Center for the Yale-New Haven Health System, effective June 4, 2018.
Internal Medicine Residency News, Jan. 15, 2018
Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for Jan. 15, 2018.
DGIM group in CJASN publication and podcast
Joseph Lunyera and Clarissa Diamantidis, published important work about psychosocial factors and kidney health in Black Americans in CJASN
Chief Residents for 2019-2020 announced
Joseph Rogers, MD, interim chair of the department, Aimee Zaas, MD, MHS, program director of the Internal Medicine Residency Program, and David Simel, MD, vice chair for Veterans Affairs, have announced the Chief Residents for the 2019-2020 academic year.
Duke study shows stem cell transplant is better than drug therapy for scleroderma
Duke study, led by Keith Sullivan, MD, shows stem cell transplant is better than drug therapy for scleroderma. The research was published in the New England Journal of Medicine on Jan. 4.
1/26/18: Special guest lecture with Dr. Joan Y. Reede
The School of Medicine Office for Faculty and Office of Diversity and Inclusion will host a special lecture with Joan Y. Reede, MD, MS, MPH, MBA, Dean for Diversity and Community Partnership at Harvard Medical School, from 12-1 p.m. on Fri., Jan. 26.